RZL-012

· Raziel Therapeutics Ltd.

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for RZL-012, covering 2019-08-21 to 2024-02-07. Get the full timeline:

Most recent: Clinical Trial Update: RZL-012 for Dercum's Disease Lipomas [Phase 2]